|
3 Companies |
|
2 Products |
|
2 Products |
|
2 Mechanisms of Action |
|
1 Trial |
|
15 News |
|
- | Trial completion date, Trial primary completion date: Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=234, Recruiting, Sponsor: Samsung Medical Center
Trial completion date: May 2018 --> May 2024 | Trial primary completion date: May 2018 --> May 2020
- | Trial primary completion date: Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism (clinicaltrials.gov) - Mar 2, 2018
P2, N=4, Completed, Sponsor: National Cancer Institute (NCI)
Trial completion date: May 2018 --> May 2024 | Trial primary completion date: May 2018 --> May 2020 Trial primary completion date: Feb 2018 --> Aug 2017
- | Trial completion, Trial completion date, Trial primary completion date: Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism (clinicaltrials.gov) - Feb 28, 2018
P2, N=4, Completed, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Feb 2018 --> Aug 2017 Active, not recruiting --> Completed | Trial primary completion date: Jul 2019 --> Feb 2018 | Trial completion date: Jul 2020 --> Feb 2018
- | Trial completion, Trial primary completion date: Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy (clinicaltrials.gov) - Oct 6, 2017
P=N/A, N=83, Completed, Sponsor: Seoul National University Hospital
Active, not recruiting --> Completed | Trial primary completion date: Jul 2019 --> Feb 2018 | Trial completion date: Jul 2020 --> Feb 2018 Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Feb 2016
- | Enrollment closed, Enrollment change, Trial primary completion date: Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism (clinicaltrials.gov) - Jun 9, 2017
P2, N=4, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed | Trial primary completion date: Sep 2016 --> Feb 2016 Recruiting --> Active, not recruiting | N=66 --> 4 | Trial primary completion date: Jul 2018 --> Jul 2019
- Enrollment closed, Trial primary completion date: Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy (clinicaltrials.gov) - Sep 19, 2016
P=N/A, N=84, Active, not recruiting, Sponsor: Seoul National University Hospital
Recruiting --> Active, not recruiting | N=66 --> 4 | Trial primary completion date: Jul 2018 --> Jul 2019 Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2017 --> Sep 2016
- Trial primary completion date: Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism (clinicaltrials.gov) - Jul 26, 2016
P2, N=66, Recruiting, Sponsor: National Cancer Institute (NCI)
Recruiting --> Active, not recruiting | Trial primary completion date: Aug 2017 --> Sep 2016 Trial primary completion date: Oct 2016 --> Jul 2018
- |||| selurampanel (BGG492) / Novartis
Trial completion, Enrollment change, Trial primary completion date: Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 (clinicaltrials.gov) - Oct 7, 2015
P2, N=59, Completed, Sponsor: Novartis Pharmaceuticals
Trial primary completion date: Oct 2016 --> Jul 2018 Recruiting --> Completed | N=77 --> 59 | Trial primary completion date: Jun 2015 --> Sep 2015
- |||| selurampanel (BGG492) / Novartis
Enrollment open, Trial primary completion date: Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 (clinicaltrials.gov) - Jan 8, 2015
P2, N=77, Recruiting, Sponsor: Novartis Pharmaceuticals
Recruiting --> Completed | N=77 --> 59 | Trial primary completion date: Jun 2015 --> Sep 2015 Not yet recruiting --> Recruiting | Trial primary completion date: Nov 2014 --> Jun 2015
- Trial primary completion date: Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism (clinicaltrials.gov) - Sep 11, 2014
P2, N=66, Recruiting, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting | Trial primary completion date: Nov 2014 --> Jun 2015 Trial primary completion date: Oct 2014 --> Oct 2016
- ||||| selurampanel (BGG492) / Novartis
New P2 trial: Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 (clinicaltrials.gov) - May 27, 2014
P2, N=77, Not yet recruiting, Sponsor: Novartis Pharmaceuticals
- Enrollment change: A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia (clinicaltrials.gov) - Feb 23, 2014
P=N/A, N=2, Terminated, Sponsor: Corcept Therapeutics
Trial primary completion date: Oct 2014 --> Oct 2016 N=150 --> 2
- | New P2 trial: Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism (clinicaltrials.gov) - Dec 2, 2013
P2, N=66, Recruiting, Sponsor: National Cancer Institute (NCI)
- Enrollment open: Comparison Between Posterior Retroperitoneoscopic Adrenalectomy and Laparoscopic Adrenalectomy (clinicaltrials.gov) - Sep 9, 2012
P=N/A, N=84, Recruiting, Sponsor: Seoul National University Hospital
N=150 --> 2 Not yet recruiting --> Recruiting
- || Korlym (mifepristone) / Corcept Therap
Trial completion: SEISMIC: A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome (clinicaltrials.gov) - Oct 20, 2011
P3, N=50, Completed, Sponsor: Corcept Therapeutics
Not yet recruiting --> Recruiting Active, not recruiting --> Completed